Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT01493843

Public ClinicalTrials.gov record NCT01493843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

Study identification

NCT ID
NCT01493843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
501 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • bevacizumab Drug
  • carboplatin Drug
  • paclitaxel Drug
  • pictilisib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2012
Primary completion
Mar 29, 2016
Completion
Mar 29, 2016
Last update posted
Apr 24, 2017

2012 – 2016

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35211
Highlands Oncology Group Rogers Arkansas 72758
cCare Encinitas California 92024
Kaiser Permanente - Oakland Oakland California 94611
Desert Hematology Oncology Group Rancho Mirage California 92270
Kaiser Permanente - Roseville Roseville California 95661
Kaiser Permanente Sacramento Medical Center Sacramento California 95825
Southern CA Permanente Med Grp San Diego California 92120
Kaiser Permanente San Francisco California 94115
K. Permanente - Santa Clara Santa Clara California 95051
Stockton Hema Onc Med Grp Inc Stockton California 95204
Kaiser Permanente - Vallejo Vallejo California 94589
K. Permanente - Walnut Creek Walnut Creek California 94596
Hematology Oncology PC; Bennett Cancer Center Stamford Connecticut 06902
Lynn Regional Cancer Center West Boca Raton Florida 33486
Florida Cancer Specialists - Fort Myers (Colonial Center Dr) Fort Myers Florida 33905
Cancer Specialists; North Florida ;Jacksonville (AC Skinner Pkwy) Jacksonville Florida 32256
Advanced Medical Specialties Miami Florida 33176
Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building) St. Petersburg Florida 33705
University Cancer & Blood Center, LLC Athens Georgia 30607
Peachtree Hematology & Oncology Consultants, Pc Atlanta Georgia 30318
Georgia Cancer Specialists Atlanta Georgia 30341
Hematology-Oncology of Indiana, Pc Indianapolis Indiana 46260
Franklin Square Hospital Baltimore Maryland 21237
Massachusetts General Hospital. Boston Massachusetts 02114
Dana Farber Cancer Inst. Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Wayne State University; Hemat/Onc, 4HW CRC Detroit Michigan 48201
Nebraska Methodist Hospital Omaha Nebraska 68114
Va Sierra Nevada Health Care System Reno Nevada 89502
San Juan Oncology Associates Farmington New Mexico 87401
Roswell Park Cancer Inst. Buffalo New York 14263
Piedmont Hematology Oncology Associates Winston-Salem North Carolina 27103
Gabrail Cancer Center Canton Ohio 44718
The Christ Hospital Cincinnati Ohio 45219
Univ Hosp Case Medical Center Cleveland Ohio 44106
Center for Biomedical Research LLC Knoxville Tennessee 37909
The Sarah Cannon Research Inst Nashville Tennessee 37203
Vanderbilt Nashville Tennessee 37232
University of Texas M.D. Anderson Cancer Center Houston Texas 77030
Wellmonth Physician Services Bristol Virginia 24201
Blue Ridge Cancer Care - Roanoke Roanoke Virginia 24014
VA Puget Sound Health Care Sys Seattle Washington 98108
Northwest Medical Specialties Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01493843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2017 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01493843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →